Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Stockholders Equity of $87.33 million for fiscal year 2025.
TREACE MEDICAL CONCEPTS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $87.33M | -22.6% |
| 2024 | $112.89M | -18.2% |
| 2023 | $137.94M | +127.9% |
| 2022 | $60.53M | -35.0% |
| 2021 | $93.07M | +11893.9% |
| 2020 | $776.0K | -75.5% |
| 2019 | $3.16M | -46.9% |
| 2018 | $5.95M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $89.19M | -15.0% | -8.6% |
| June 30, 2025 | $97.61M | -13.0% | -7.3% |
| March 31, 2025 | $105.34M | -16.7% | -6.7% |
| December 31, 2024 | $112.89M | -18.2% | +7.6% |
| September 30, 2024 | $104.91M | -23.9% | -6.5% |
| June 30, 2024 | $112.14M | -25.2% | -11.3% |
| March 31, 2024 | $126.39M | -19.8% | -8.4% |
| December 31, 2023 | $137.94M | +127.9% | +0.1% |
- TREACE MEDICAL CONCEPTS, INC. showed a decrease of -22.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, TREACE MEDICAL CONCEPTS, INC.’s stockholders equity has grown by 1368.3% (from $5.95 million to $87.33 million).
- The most recent figure is from TREACE MEDICAL CONCEPTS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: